Forward Pharma A/S
FWPAY · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $226 | $327 | $1,049 | $2,748 |
| G&A Expenses | $3,648 | $3,059 | $4,234 | $9,535 |
| SG&A Expenses | $3,648 | $3,059 | $4,234 | $9,535 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,874 | $3,386 | $5,283 | $12,283 |
| Operating Income | -$3,874 | -$3,386 | -$5,283 | -$12,283 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,982 | -$3,063 | $1,062 | $3,357 |
| Pre-Tax Income | -$1,892 | -$6,449 | -$4,221 | -$8,926 |
| Tax Expense | $0 | $0 | $0 | -$204 |
| Net Income | -$1,892 | -$6,449 | -$4,221 | -$8,722 |
| % Margin | – | – | – | – |
| EPS | -77.41 | -268.72 | -177.58 | -368.51 |
| % Growth | 71.2% | -51.3% | 51.8% | – |
| EPS Diluted | -77.41 | -268.72 | -177.58 | -368.51 |
| Weighted Avg Shares Out | 24 | 24 | 24 | 24 |
| Weighted Avg Shares Out Dil | 24 | 24 | 24 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$2,170 | $2,970 | $1 | $4 |
| EBITDA | -$6,044 | -$416 | -$6,041 | -$14,992 |
| % Margin | – | – | – | – |